Abstract: Objective To investigate the influence of two non-biological artificial liver on cytokines and
clinical effect of patients with hepatitis B related acute-on-chronic liver failure. Methods Total of 97 chronic
hepatitis B patients with acute-on-chronic liver failure in the First Affiliated Hospital of Guangxi University
of Chinese Medicine from December 2012 to April 2015 were selected and divided into PE group (50 cases)
and PEF group (47 cases). The liver function, blood ammonia, serum creatinine, tumor necrosis factor
alpha, interleukin-6 and interleukin-10 were detected and compared between the two groups before and after
treatment. Results ①The clinical symptoms improved in different degree in two groups, the recovery rate of
PEF group (76.5%) was higher than that of PE group (56%), the difference was statistically significant (χ 2 =
4.578, P = 0.032). ②Compared with before treatment, TBil (t = 3.746, 3.826; P = 0.000, 0.000), ALT (t = 5.123,
4.881; P = 0.000, 0.000), AMMO (t = 2.802, 6.996; P = 0.006, 0.000), INR (t = 1.996, 2.038; P = 0.049, 0.044)
and Cr (t = 2.187, 4.802; P = 0.031, 0.000) decreased and ALB (t = 2.300, 3.065; P = 0.024, 0.003) increased
significantly after treatment in both groups. After treatment, the levels of AMMO and Cr in PE and FEF group
decreased significantly, and there were statistical difference (t = 2.111, 2.152, P = 0.037, 0.034). ③After
treatment, compared with PEF group, the levels of TNF-α, IL-10 and IL-6 were much lower in PE group,
the difference was statistically significant (t = 2.012, 2.234, 2.339, P = 0.047, 0.027, 0.021). Conclusions
PE was more suitable for the early treatment in patients with acute-on-chronic liver failure associated with
hepatitis B virus infection. PEF was more suitable for the treatment of middle liver failur, because it can not
only obviously improve the hepatic function and coagulation function, but also reduce the blood ammonia,
creatinine and inflammatory cytokines.
|